Listen in to this recording to learn more about a potential clinical trial for your patients. The RAMP 301 trial is evaluating the novel combination of avutometinib + defactinib versus investigator’s choice of therapy in patients with recurrent low grade serous ovarian cancer.

Recorded on April 15, 2024
Duration approximately 30 minutes

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

If you have questions or need assistance, contact education@igcs.org.

	Rachel Grisham, MD Section Head Ovarian Cancer Director, Gynecologic Medical Oncology Memorial Sloan Kettering Cancer Center USA
	Susana Banerjee, MBBS, MA, PhD, FRCP Consultant Medical Oncologist Research Lead Gynaecology Unit The Royal Marsden UK